(Q44351067)

English

The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats

scientific article published in December 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

author name string

June HL

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Grey C

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Warren-Reese C

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Durr LF

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Ricks-Cord A

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Johnson A

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

McCane S

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Williams LS

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mason D

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Cummings R

10

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Lawrence A

11

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 December 1998

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Alcoholism: Clinical and Experimental Research

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2174-2185

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Effect of naltrexone on alcohol "high" in alcoholics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Endogenous opioid systems and alcohol addiction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Dosing issues in the pharmacotherapy of alcoholism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Ethanol reinforcement in the alcohol nonpreferring rat: initiation using behavioral techniques without food restriction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Nalmefene: safety and kinetics after single and multiple oral doses of a new opioid antagonist

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Stimulus effects of morphine in the monkey: quantitative analysis of antagonism.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Pharmacologic profile of NPC 168 (naltrexone phenyl oxime), a novel compound with activity at opioid receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Imaging dopamine receptors in the human brain by positron tomography.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Quantitative imaging of neuroreceptors in the living human brain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Periodic naltrexone and propensity to take alcoholic beverage.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB05931.X

21 January 2018

Identifiers

10.1111/J.1530-0277.1998.TB05931.X

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44351067&oldid=2109649042"